Arcadia Biosciences
RKDA
Arcadia Biosciences (RKDA) - Total debt
Total debt on the balance sheet as of September 2023 : $1.27 M
According to Arcadia Biosciences's latest financial reports the company's total debt is $1.27 M. A company’s total debt is the sum of all current and non-current debts.
Arcadia Biosciences - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $2.01 M | -38.77% |
| 2021-12-31 | $3.29 M | -64.78% |
| 2020-12-31 | $9.35 M | 317.69% |
| 2019-12-31 | $2.23 M | |
| 2018-12-31 | $N/A | |
| 2016-12-31 | $25.12 M | 0.79% |
| 2015-12-31 | $24.93 M | 72.23% |
| 2014-12-31 | $14.47 M | -0.61% |
| 2013-12-31 | $14.56 M | 82.05% |
| 2012-12-31 | $8 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Marrone Bio Innovations
MBII | N/A | N/A | 🇺🇸 USA |
 Codexis
CDXS | $16.02 M | 1,160.74% | 🇺🇸 USA |
 ScottsMiracle-Gro SMG | $3.02 B | 237,783.56% | 🇺🇸 USA |
 American Vanguard AVD | $0.24 B | 18,912.98% | 🇺🇸 USA |